April 7, 2022
Lowered levels of phosphorylated (P)-tau217 and glial fibrillary acidic protein (GFAP) in the blood indicate downstream treatment effects of beta amyloid (Aβ) clearance from the brain, […]
April 7, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways To enable early intervention, […]
April 7, 2022
Stem cell therapy improves motor impairment and is safe and well tolerated in patients with traumatic brain injury (TBI), results from a phase 2 trial indicate. […]
April 7, 2022
The study covered in this summary was published on papers.ssrn.com as a preprint and has not yet been peer reviewed. Key Takeaways Loneliness and dementia are […]
April 7, 2022
Dr Matthew Kiernan A novel treatment for amyotrophic lateral sclerosis (ALS) that targets brain cell energy production to promote remyelination showed signs of efficacy in a […]
April 6, 2022
SEATTLE – Use of antiseizure medications while breastfeeding is not associated with differences in child cognitive outcomes at age 3, according to new results from the […]
April 6, 2022
Trofinetide (Acadia Pharmaceuticals) is effective in improving symptoms in girls and young women with Rett syndrome (RTT), a rare and devastating neurodevelopmental disorder, results from a […]
April 6, 2022
Daily corticosteroid use is significantly more effective than an intermittent regimen for improving motor function in patients with Duchenne muscular dystrophy (DMD), a new study suggests. […]
April 5, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Neuroendoscopy for the treatment […]